TABLE 3.

System-Use Parameters (n = 58)

Parameter	2 Weeks	Third Month	Sixth Month
CGM scans/day*	9.0 ± 5.1†	6.4 ± 3.9	6.3 ± 4.2
Rapid-acting insulin doses/person/day	3.1 ± 1.3‡	2.7 ± 1.0	2.6 ± 1.1
Long-acting insulin doses/person/week	7.2 ± 3.0	6.7 ± 2.5	6.7 ± 2.2
Long-acting insulin dose alerts/person/week	1.1 ± 0.8	1.0 ± 0.8	1.1 ± 1.0
Long-acting insulin alerts followed by dose within 2 hours, %§	73.8 ± 33.9	74.0 ± 28.8	71.6 ± 32.4
Individuals with insulin dose adjustments, n (%)	10 (17.2)	14 (24.1)	10 (17.2)
HCP engagement interactions/patient/week	2.1 ± 2.3	2.4 ± 1.8	2.6 ± 2.1
Patient engagement interactions/person/day	22.1 ± 9.8†	14.5 ± 8.3	14.0 ± 7.2

Data are mean ± SD or n (%).

^*n = 57 for third month.

^†ANOVA and subsequent pairwise comparisons showed a statistically significant difference for the first 2 weeks compared with the third and sixth months (P <0.05).

^‡Friedman test and subsequent pairwise comparisons showed a statistically significant difference for the first 2 weeks compared with the third and sixth months (P <0.05); no other variables were found to be statistically significant using statistics appropriate to the distribution.

^§n = 46 for 2 weeks and n = 48 for the third and sixth months, reflecting those who received an alert.